by Mike Masnick
Mon, Mar 26th 2012 8:03pm
As we expected, following the Supreme Court's excellent rejection of medical diagnostic patents, it's now set aside the appeals court's ruling upholding gene patents, and asked the appeals court to review the case in light of its ruling last week. Again, this is not a surprise, but it's good that the court so quickly recognized that the two cases have similar issues, and that the appeals court ought to revisit the Myriad (gene patents) ruling so quickly. Hopefully, CAFC (the appeals court in question) will come to its senses and recognize that you can't patent genes. Either way, no matter what CAFC decides, expect that to also be appealed right back to the Supreme Court.
If you liked this post, you may also be interested in...
- Travesty: Supreme Court (And Senate) Deny SCOTUSblog A Press Pass
- Microsoft And Sony Double Down On Patent Trolling; Dump More Cash Into Intellectual Ventures
- USPTO Keeps Granting Patents At Record Rates: 6,000 Utility Patents Granted In A Single Week
- Myriad Genetics Loses Again: Court Refuses To Grant Preliminary Injunction Against Rival Genetic Testing Company
- US Court Rules Again That Natural Phenomena Cannot Be Patented, Casting Further Doubt On Gene Patents